Abiopharma

New Form S-8 - CDT Equity Inc. Filed: 2025-08-11 AccNo: 0001641172-25-023010 Size: 339 KB

New Form 8-K - Biofrontera Inc. Filed: 2025-08-11 AccNo: 0001641172-25-023006 Size: 427 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 144 - STERIS plc Filed: 2025-08-11 AccNo: 0001921094-25-000923 Size: 4 KB

Summit Plc - Quarterly report pursuant to sections 13 or 15(d)

New Form 8-K - Quipt Home Medical Corp. Filed: 2025-08-11 AccNo: 0001558370-25-011079 Size: 280 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form S-8 - Protara Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001213900-25-074386 Size: 220 KB

New Form 144 - STERIS plc Filed: 2025-08-11 AccNo: 0001921094-25-000922 Size: 4 KB

New Form 144 - STERIS plc Filed: 2025-08-11 AccNo: 0001921094-25-000921 Size: 4 KB

New Form 13F-HR - PFIZER INC Filed: 2025-08-11 AccNo: 0000078003-25-000142 Size: 12 KB

New Form 144 - STERIS plc Filed: 2025-08-11 AccNo: 0001921094-25-000920 Size: 4 KB

New Form 4 - BeyondSpring Inc. Filed: 2025-08-11 AccNo: 0001415889-25-021441 Size: 43 KB

New Form 4 - Embecta Corp. Filed: 2025-08-11 AccNo: 0000947871-25-000735 Size: 5 KB

New Form 10-Q - Quipt Home Medical Corp. Filed: 2025-08-11 AccNo: 0001558370-25-011076 Size: 6 MB

New Form 3 - BeyondSpring Inc. Filed: 2025-08-11 AccNo: 0001415889-25-021439 Size: 16 KB

New Form SCHEDULE 13G/A - OptiNose, Inc. Filed: 2025-08-11 AccNo: 0001579206-25-000010 Size: 12 KB